Clinical trial
Treatment for Patients With Osteoarthritis (OA) of the Knee
NCT00110916 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00110916 |
|---|---|
| Title | Treatment for Patients With Osteoarthritis (OA) of the Knee |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Intra-Articular metHuIL-1ra (Anakinra) in Subjects With Osteoarthritis (OA) of the Knee |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Intra-articular metHuIL-1ra (anakinra), placebo |
| Enrollment | 165 |
| Start date | Jun 1, 2004 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | May 17, 2005 |
| Last update posted | Feb 22, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: